Does the oncotype DX assay recurrence score correlate with other predictive tools when planning adjuvant chemotherapy in early breast cancer?. (November 2016) - Blower, E.; Sridharan, U.; Kiernan, T.; Tansley, A.; Mitchell, G.; Holcombe, C.